These comparisons revealed a clear decrease in tumor size and growth in the STEAP2 shRNA1 and shRNA2-transfected groups when compared to those in the control and a significant increase in both of these parameters in the STEAP2-overexpressing groups (Figure 4a). The gene discussed is STEAP2; the disease is neoplasm.